← Back to Search

Telehealth Suicide Prevention Strategies for Suicidal Thoughts

N/A
Waitlist Available
Led By Gregory K Brown, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aim 1/Aim 3: 18 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before ed crosses over to spc condition (1 - 1.75 year range, average of 1.375 years)
Awards & highlights

Study Summary

This trial will compare two suicide prevention strategies to see which is more effective. One will be delivered by emergency department staff, and the other will be delivered by referral to an off-site suicide prevention consultation center.

Who is the study for?
This trial is for adults who visited the emergency department (ED) for suicide-related issues or are at risk of suicide, can communicate in English, and have access to a phone. They must be willing to consent and not require immediate psychiatric hospitalization. It's not for those admitted as inpatients right after their ED visit or who are acutely psychotic.Check my eligibility
What is being tested?
The study compares two ways of delivering a suicide prevention plan with follow-up calls (SPI+) in EDs: one by the ED staff directly, and another via referral to an off-site Suicide Prevention Consultation Center (SPCC). The goal is to see which method works best when using telehealth services.See study design
What are the potential side effects?
Since this trial involves psychological support interventions rather than medications, traditional side effects aren't expected. However, participants may experience emotional discomfort discussing suicidal thoughts or distress during intervention sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before ed crosses over to spc condition (1 - 1.75 year range, average of 1.375 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and before ed crosses over to spc condition (1 - 1.75 year range, average of 1.375 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fidelity of Follow-up Calls
Outpatient Treatment Engagement - Count
Outpatient Treatment Engagement - Type
+4 more
Secondary outcome measures
Acceptability of SPCC
Adoption
Cost to Emergency Department of EUC
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Suicide Prevention Consultation CenterExperimental Treatment1 Intervention
ED staff refer suicidal patients not admitted to an inpatient unit to the off-site Suicide Prevention Consultation Center (SPCC). SPCC clinicians will deliver SPI+ (Safety Planning Intervention plus 2 or more post-discharge telephone calls) to patients via telehealth.
Group II: Enhanced Usual CareActive Control1 Intervention
ED staff deliver SPI+ (Safety Planning Intervention plus 2 or more post-discharge telephone calls) to suicidal patients who are not admitted to an inpatient unit.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,879,469 Total Patients Enrolled
16 Trials studying Suicide
54,699 Patients Enrolled for Suicide
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,686,885 Total Patients Enrolled
112 Trials studying Suicide
1,154,005 Patients Enrolled for Suicide
Gregory K Brown, PhDPrincipal InvestigatorUniversity of Pennsylvania

Media Library

SPI+ Delivered by ED Staff Clinical Trial Eligibility Overview. Trial Name: NCT05307432 — N/A
Suicide Research Study Groups: Enhanced Usual Care, Suicide Prevention Consultation Center
Suicide Clinical Trial 2023: SPI+ Delivered by ED Staff Highlights & Side Effects. Trial Name: NCT05307432 — N/A
SPI+ Delivered by ED Staff 2023 Treatment Timeline for Medical Study. Trial Name: NCT05307432 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment opportunities available for this experiment currently?

"According to the clinicaltrials.gov, this medical trial is not accepting applicants at present. Originally posted on May 1st 2022 and last updated on June 27th 2022, it appears that recruitment has been concluded for now. Nonetheless, there are 397 other trials actively looking for participants today."

Answered by AI

What is the primary purpose of this clinical research?

"The primary measurement of success for this trial over the 1-month after initial ED visit period is Suicide Behavior Composite. Secondary endpoints include costs to Emergency Department practices associated with EUC strategies, screening suicide risk among ED patients, and gauging the feasibility of SPCC as measured by Feasibility of Intervention Measure (FIM)."

Answered by AI
~1520 spots leftby Jul 2026